The Valley Desk

NCT04040322 · Interventional trial

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)

Overall registry status Completed

Phase 3

Conditions Raynaud's Phenomenon Secondary to Systemic Sclerosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov